EN PL
ARTYKUŁ REDAKCYJNY
Stem cell transplantation for systemic sclerosis: many steps forward in Poland
 
Więcej
Ukryj
 
Data publikacji online: 11-02-2016
 
 
Reumatologia 2015;53(6):297-300
 
 
REFERENCJE (10)
1.
van Laar JM, Farge D, Sont JK, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014; 311: 2490-2498.
 
2.
van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/ European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-2747.
 
3.
Verrecchia F, Laboureau J, Verola O, et al. Skin involvement in scleroderma – where histological and clinical scores meet. Rheumatology (Oxford) 2007; 46: 833-841.
 
4.
Launay D, Marjanovic Z, de Bazelaire C, et al. Autologous hematopoietic stem cell transplant in systemic sclerosis: quantitative high resolution computed tomography of the chest scoring. J Rheumatol 2009; 36: 1460-1463.
 
5.
Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases. Haematologica 2010; 95: 284-292.
 
6.
Nannini C, West CP, Erwin PJ, Matteson EL. Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies. Arthritis Res Ther 2008; 10: R124.
 
7.
Burt RK, Shah SJ, Dill K, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498-506.
 
8.
Farge D, Henegar C, Carmagnat M, et al. Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosis. Arthritis Rheum 2005; 52: 1555-1563.
 
9.
Snowden JA, Saccardi R, Allez M, et al. on behalf of the EBMT Autoimmune Disease (ADWP) and Paediatric Diseases (PDWP) Working Parties. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow transplantation (EBMT). Bone Marrow Transplant 2012; 47: 770-790.
 
10.
Alexander T, Bondanza A, Muraro PA, et al. Stem cell transplantation for severe autoimmune diseases: consensus guidelines of the European Group for Blood and Marrow Transplantation (EBMT) for immune monitoring and biobanking. Bone Marrow Transplant 2015; 50: 173-180.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top